RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Fox News senior medical analyst Dr. Marc Siegel reveals what he learned from his interview with National Institutes of Health ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

Exosomes, naturally derived vesicles responsible for intercellular communication, are emerging as next-generation drug ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.